Enanta Pharmaceuticals ENTA
NASDAQ ENTA
$11.60 +0.38 (+3.39%)
At close: Nov 11, 2026 · 4:00 PM EST

Enanta Pharmaceuticals (ENTA) Total Liabilities (2012 - 2026)

Updated

Enanta Pharmaceuticals (ENTA) recorded Total Liabilities of $195.8 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 11.7% from $221.75 million a year earlier and down 1.2% from the prior quarter.

Analysis

Enanta Pharmaceuticals (ENTA) Total Liabilities (2012 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Enanta Pharmaceuticals reported Total Liabilities of $216.02 million, down 12.8% from FY2024.

  • Annual Total Liabilities has a five-year compound annual growth rate of 47.9% (FY2020 to FY2025).
  • Across earlier fiscal years, Total Liabilities came in at $247.84 million in FY2024 (+0.9%), $245.54 million in FY2023 (+354.1%), $54.08 million in FY2022 (+37.4%) and $39.36 million in FY2021 (+28.8%).
  • The fiscal Q3 2026 figure is the lowest quarterly Total Liabilities since fiscal Q2 2023.
  • On a year-over-year basis, Total Liabilities has declined for six consecutive quarters, with an average decline of 8.8% over the last eight quarters.
  • Peak year-over-year performance for Total Liabilities in the last five years was growth of 445.3% in fiscal Q3 2023, against a decline of 16.9% in fiscal Q1 2023 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $198.12 million (Q2 2026), $202.91 million (Q1 2026) and $216.02 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 107.80 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 115.90 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 152.26 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 87.83 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 68.11 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 81.70 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 38.37 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 115.70 Bn
10 Enanta Pharmaceuticals 326.73 Mn -401.27 Mn - 195.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 195.80 Mn
Mar 31, 2026 198.12 Mn
Dec 31, 2025 202.91 Mn
Sep 30, 2025 216.02 Mn
Jun 30, 2025 221.75 Mn
Mar 31, 2025 229.46 Mn
Dec 31, 2024 236.83 Mn
Sep 30, 2024 247.84 Mn
Jun 30, 2024 249.91 Mn
Mar 31, 2024 247.44 Mn
Dec 31, 2023 236.62 Mn
Sep 30, 2023 245.54 Mn
Jun 30, 2023 257.35 Mn
Mar 31, 2023 57.07 Mn
Dec 31, 2022 46.70 Mn
Sep 30, 2022 54.08 Mn
Jun 30, 2022 47.19 Mn
Mar 31, 2022 48.24 Mn
Dec 31, 2021 56.21 Mn
Sep 30, 2021 39.36 Mn
API Access

Enanta Pharmaceuticals Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=ENTA&period=max&api_key=YOUR_API_KEY